Highlight Articles

Featured image
Journal of Infectious Diseases and Treatment Publishes Positive Trial Data of Aviptadil in High Comorbidity Patients Suffering from Critical COVID-19 with Respiratory Failure

Seventeen of 21 Patients Treated with Aviptadil Survived to Day 60 Compared to 5 of 24 in the Controlled Group of Patients RADNOR, Pa., Oct. 14, 2021 /PRNewswire/ — NRx Pharmaceuticals (Nasdaq: NRXP), today announced […]

Continue Reading
Featured image
NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)

ZYESAMI™ (aviptadil) Has Previously Demonstrated a Statistically Significant Increase in Survival of Highly Comorbid COVID-19 Patients in Two 60-day TrialsIn a Study of Highly Comorbid Patients, ZYESAMI Provided a Threefold, […]

Continue Reading
3PLAccelerated RecoveryACTIV-3Acute Respiratory FailureAdaptive Platform Trial DesignAnthony S Fauci MDARDSAviptadilAvitpadilBARDABig Rock PartnersBipolar DepressionBoosterBRilifeCardinal HealthCH HealthChaim HurvitzCheddar NewsClinical TrialsClosing BellCommercial ForumlationCovid-19COVID-19 SurvivalCritical COVID-19CromosCytokine IL-6Cytokine StormCytokinesData Safety Monitoring BoardDelta VariantDenk PharmaDr YoDry-powder InhalerDSMBEAPEkaterine TikaradzeEmegency Use AuthorizationEmergency UseEmergency Use AuthorizationEUAExpanded AccessFast TrackFDAFDA Emergency Use AuthorizationFDA Module 3Fox BusinessGeorgiaGILDGileadH.C. Wainwright & Co.HC WainwrightHC Wainwright Annual Global Investment ConferenceHigh Flow NasalHoustonHouston MethodistHouston Methodist JC Walkter Jr Transplant CenterI-Spyi24 NewsIIBRIL-6 CytokineInhaled AviptadilIQVIQVIAiSpyIsraelIsrael Institute of Biological ResearchJ&JJihad Georges YoussefJihad Georges Youssef MDJihad Geroges YoussefJournal of Infectious Diseases and TreatmentMannkindNASDAQNation of GeorgiaNDA ZyesamiNehpron PharmaceuticalsNephronNIAIDNIHNRX-100NRX-100/101NRX-101NRXPOrphan Drug DesignationPeptidesPharmacovigilancePrivate PlacementPTSDQ2 EarningsQuantum Leap HealthcareRemdesivirRespiratory Distress RatioRespiratory FailureRichard G Lugar Center for Public HealthRichard Luger CenterRLF-100RLF-100_002Sar-CoV-2Sever COVID-19Suicidal DepressionTechnosphereTESICOUCIUkraineVaccineVaccine TrialVasoactive Intestinal PeptideVekluryVIPVirologyZYESAMIZYESAMI™Zysami